Cargando…

High BLM Expression Predicts Poor Clinical Outcome and Contributes to Malignant Progression in Human Cholangiocarcinoma

Molecular mechanisms underlying the tumorigenesis of a highly malignant cancer, cholangiocarcinoma (CCA), are still obscure. In our study, the CCA expression profile data were acquired from The Cancer Genome Atlas (TCGA) database, and differentially expressed genes (DEGs) in the TCGA-Cholangiocarcin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Du, Xiaolong, Zhang, Chen, Yin, Chuanzheng, Wang, Wenjie, Yan, Xueke, Xie, Dawei, Zheng, Xichuan, Zheng, Qichang, Li, Min, Song, Zifang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019910/ https://www.ncbi.nlm.nih.gov/pubmed/33828983 http://dx.doi.org/10.3389/fonc.2021.633899

Ejemplares similares

Development of a novel lipid metabolism-based risk score model in hepatocellular carcinoma patients
por: Wang, Wenjie, et al.
Publicado: (2021)

Sox9 mediates autophagy-dependent vascular smooth muscle cell phenotypic modulation and transplant arteriosclerosis
por: Yu, Qihong, et al.
Publicado: (2022)

Nuclear respiratory factor 1 drives hepatocellular carcinoma progression by activating LPCAT1-ERK1/2-CREB axis
por: Liu, Ran, et al.
Publicado: (2023)

Progress in Radiotherapy for Cholangiocarcinoma
por: Wang, Ningyu, et al.
Publicado: (2022)

BLM SUMOylation regulates ssDNA accumulation at stalled replication forks
por: Ouyang, Karen J., et al.
Publicado: (2013)

Malignant Progression Contributes to the Failure of Combination Therapy for Atypical Meningiomas
por: Zhang, Qing, et al.
Publicado: (2021)

PUF60/AURKA Axis Contributes to Tumor Progression and Malignant Phenotypes in Bladder Cancer
por: Long, Qian, et al.
Publicado: (2020)

Dysregulation of the Immune Microenvironment Contributes to Malignant Progression and Has Prognostic Value in Bladder Cancer
por: Zheng, Zongtai, et al.
Publicado: (2020)

Downregulation of DUSP9 Promotes Tumor Progression and Contributes to Poor Prognosis in Human Colorectal Cancer
por: Qiu, Zhaoyan, et al.
Publicado: (2020)

Editorial: Transcription Factors Drivers of Malignancy, Progression and Poor Outcomes in Breast Cancer
por: Parisi, Eva, et al.
Publicado: (2022)

PI3Kγ promotes vascular smooth muscle cell phenotypic modulation and transplant arteriosclerosis via a SOX9-dependent mechanism
por: Yu, Qihong, et al.
Publicado: (2018)

Cholangiocarcinoma Presenting as Humoral Hypercalcemia of Malignancy: A Case Report and Literature Review
por: Erdinc, Burak, et al.
Publicado: (2019)

Small Nuclear Ribonucleoprotein Polypeptide N Accelerates Malignant Progression and Poor Prognosis in Colorectal Cancer Transcriptionally Regulated by E2F8
por: Ji, Meiling, et al.
Publicado: (2020)

Liver Transplantation for Intrahepatic Cholangiocarcinoma: What Are New Insights and What Should We Follow?
por: Sun, Dawei, et al.
Publicado: (2022)

Terminal fucosylation of haptoglobin in cancer-derived exosomes during cholangiocarcinoma progression
por: Choi, Hyewon, et al.
Publicado: (2023)

BLM Thresholds and UFOs
por: Lechner, A, et al.
Publicado: (2017)

RecQ helicase BLM regulates prostate cancer cell proliferation and apoptosis
por: Qian, Xiaosong, et al.
Publicado: (2017)

High PPT1 expression predicts poor clinical outcome and PPT1 inhibitor DC661 enhances sorafenib sensitivity in hepatocellular carcinoma
por: Xu, Jianjun, et al.
Publicado: (2022)

Novel Nomogram for Preoperative Prediction of Early Recurrence in Intrahepatic Cholangiocarcinoma
por: Liang, Wenjie, et al.
Publicado: (2018)

Identification of a seven-lncRNAs panel that serves as a prognosis predictor and contributes to the malignant progression of laryngeal squamous cell carcinoma
por: Zheng, Xiwang, et al.
Publicado: (2023)

The Potential Use of Dynamics Changes of ctDNA and cfDNA in the Perioperative Period to Predict the Recurrence Risk in Early NSCLC
por: Zhao, Xiaolong, et al.
Publicado: (2021)

Downregulation of Fat Mass and Obesity Associated (FTO) Promotes the Progression of Intrahepatic Cholangiocarcinoma
por: Rong, Zhuo-Xian, et al.
Publicado: (2019)

The Application Progress of Patient-Derived Tumor Xenograft Models After Cholangiocarcinoma Surgeries
por: Wu, Jun, et al.
Publicado: (2021)

Long Non-Coding RNA-PAICC Promotes the Tumorigenesis of Human Intrahepatic Cholangiocarcinoma by Increasing YAP1 Transcription
por: Xia, Long, et al.
Publicado: (2021)

Contribution of Diffusion-Weighted Imaging and ADC Values to Papillary Breast Lesions
por: Lv, Wenjie, et al.
Publicado: (2022)

BEAM LOSS MONITORING - BLM
por: Vanden Broeck, Renilde
Publicado: (2019)

BLM thresholds: limiting locations
por: Nordt, A, et al.
Publicado: (2010)

Regulation of BLM Nucleolar Localization
por: Tangeman, Larissa, et al.
Publicado: (2016)

Interventional Treatment for Cholangiocarcinoma
por: Li, Hang, et al.
Publicado: (2021)

TopBP1 Interacts with BLM to Maintain Genome Stability but Is Dispensable for Preventing BLM Degradation
por: Blackford, Andrew N., et al.
Publicado: (2015)

DEPDC1B promotes development of cholangiocarcinoma through enhancing the stability of CDK1 and regulating malignant phenotypes
por: Zhang, Zhenhai, et al.
Publicado: (2022)

Driver Gene Alterations in Malignant Progression of Gastric Cancer
por: Dong, Yuanqiang, et al.
Publicado: (2022)

Covered versus Uncovered Self-Expandable Metal Stents for Managing Malignant Distal Biliary Obstruction: A Meta-Analysis
por: Li, Jinjin, et al.
Publicado: (2016)

Exosomal Cripto-1 Serves as a Potential Biomarker for Perihilar Cholangiocarcinoma
por: Hu, Chunxiao, et al.
Publicado: (2021)

Identification of Immune-Related Prognostic Biomarkers Based on the Tumor Microenvironment in 20 Malignant Tumor Types With Poor Prognosis
por: Liu, Yu, et al.
Publicado: (2020)

Progression Patterns and Post-Progression Survival in Recurred Intrahepatic Cholangiocarcinoma Patients: A Novel Prognostic Nomogram Based on Multicenter Cohorts
por: Zhao, Chongyu, et al.
Publicado: (2022)

Overexpression of GINS4 Is Associated With Tumor Progression and Poor Survival in Hepatocellular Carcinoma
por: Zhang, Ziying, et al.
Publicado: (2021)

Overcome Drug Resistance in Cholangiocarcinoma: New Insight Into Mechanisms and Refining the Preclinical Experiment Models
por: Zheng, Qingfan, et al.
Publicado: (2022)

Development and Validation of a Nomogram for Differentiating Combined Hepatocellular Cholangiocarcinoma From Intrahepatic Cholangiocarcinoma
por: Wang, Tao, et al.
Publicado: (2020)

The Clinicopathological and Prognostic Value of PD-L1 Expression in Cholangiocarcinoma: A Meta-Analysis
por: Xu, Gang, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_qclj0roql9kcu05rrpc3brqd5m